Merck invests more than € 300 million into a new Bioprocessing Production Center in Daejeon, South Korea. The new site is the largest investment by Merck’s Life Science business sector in Asia-Pacific to date and demonstrates the company’s commitment to…
Merck will open a new, € 20 million distribution center in Cajamar, São Paulo, Brazil to better serve its Life Science customers in the region. The new space, which will be operational in late February, has an area of 13,000…
Among other roles, Kleinemeier was a member of the Executive Board of SAP SE, Walldorf, as Head of SAP Digital Business Services from 2015 to 2020. He has been a member of the Merck Supervisory Board since 2019. The election…
Merck Healthcare today announced a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds. Ompenaclid is currently being evaluated in a Phase II study for the second-line…
Merck Group today launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule design and real-world manufacturability through SynthiaTM retrosynthesis software application programing interface (API) integration. It combines generative AI, machine learning and…
Merck Healthcare has launched ChemisTwin™, the first digital reference materials platform that can perform automatic analysis of samples’ purity, identification, and degradation of compounds through calibrated algorithm-based digital references. With digital signatures for more than 1,500 reference materials, this automation…
Merck Healthcare, will cover 100% of its current electricity purchases in the EU and Switzerland with renewable energy certificates from 2025 onwards. To this end, the company has signed virtual power purchase agreements for a total of around 300 gigawatt…